FREDRIC N ESHELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of FREDRIC N ESHELMAN
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: < prev 1 2 3 4 5 6 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.56 | 1,300 | 50,128 | 8,403,826 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.55 | 530 | 20,432 | 8,405,126 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.54 | 900 | 34,686 | 8,405,656 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.53 | 370 | 14,256 | 8,406,556 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.52 | 1,300 | 50,076 | 8,406,926 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.51 | 300 | 11,553 | 8,408,226 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.50 | 400 | 15,400 | 8,408,526 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.49 | 1,000 | 38,490 | 8,408,926 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.48 | 1,500 | 57,720 | 8,409,926 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.47 | 1,000 | 38,470 | 8,411,426 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.46 | 1,161 | 44,652 | 8,412,426 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.45 | 539 | 20,725 | 8,413,587 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.44 | 300 | 11,532 | 8,414,126 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.43 | 300 | 11,529 | 8,414,426 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.42 | 200 | 7,684 | 8,414,726 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.41 | 500 | 19,205 | 8,414,926 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.40 | 400 | 15,360 | 8,415,426 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.39 | 800 | 30,712 | 8,415,826 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.38 | 400 | 15,352 | 8,416,626 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.37 | 500 | 19,185 | 8,417,026 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.36 | 100 | 3,836 | 8,417,526 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.35 | 100 | 3,835 | 8,417,626 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.34 | 400 | 15,336 | 8,417,726 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.33 | 300 | 11,499 | 8,418,126 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.32 | 300 | 11,496 | 8,418,426 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.31 | 200 | 7,662 | 8,418,726 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.30 | 300 | 11,490 | 8,418,926 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.29 | 200 | 7,658 | 8,419,226 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.28 | 300 | 11,484 | 8,419,426 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.27 | 500 | 19,135 | 8,419,726 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.26 | 400 | 15,304 | 8,420,226 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.25 | 600 | 22,950 | 8,420,626 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.24 | 1,700 | 65,008 | 8,421,226 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.23 | 900 | 34,407 | 8,422,926 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.22 | 200 | 7,644 | 8,423,826 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.21 | 100 | 3,821 | 8,424,026 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.20 | 500 | 19,100 | 8,424,126 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.19 | 600 | 22,914 | 8,424,626 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.18 | 500 | 19,090 | 8,425,226 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.17 | 400 | 15,268 | 8,425,726 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.16 | 2,200 | 83,952 | 8,426,126 | 8.4 M to 8.4 M (-0.03 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.15 | 2,697 | 102,891 | 8,428,326 | 8.4 M to 8.4 M (-0.03 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.14 | 1,337 | 50,993 | 8,431,023 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.13 | 700 | 26,691 | 8,432,360 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.12 | 500 | 19,060 | 8,433,060 | 8.4 M to 8.4 M (-0.01 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.11 | 100 | 3,811 | 8,433,560 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.09 | 100 | 3,809 | 8,433,660 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.07 | 8 | 305 | 8,433,760 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.06 | 92 | 3,502 | 8,433,768 | 8.4 M to 8.4 M (0.00 %) |
| Jul 17 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.99 | 100 | 3,799 | 8,433,860 | 8.4 M to 8.4 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.56 | 100 | 3,856 | 8,433,960 | 8.4 M to 8.4 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.55 | 400 | 15,420 | 8,434,060 | 8.4 M to 8.4 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.54 | 300 | 11,562 | 8,434,460 | 8.4 M to 8.4 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.52 | 400 | 15,408 | 8,434,460 | 8.4 M to 8.4 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.51 | 1,500 | 57,765 | 8,435,160 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.50 | 2,700 | 103,950 | 8,436,660 | 8.4 M to 8.4 M (-0.03 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.49 | 3,000 | 115,470 | 8,439,360 | 8.4 M to 8.4 M (-0.04 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.48 | 1,500 | 57,720 | 8,442,360 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.47 | 1,633 | 62,822 | 8,443,860 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.46 | 1,825 | 70,190 | 8,445,493 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.45 | 1,600 | 61,520 | 8,447,318 | 8.4 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.44 | 2,100 | 80,724 | 8,448,918 | 8.5 M to 8.4 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.43 | 1,335 | 51,304 | 8,451,018 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.42 | 2,340 | 89,903 | 8,452,353 | 8.5 M to 8.5 M (-0.03 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.41 | 1,100 | 42,251 | 8,454,693 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.40 | 600 | 23,040 | 8,455,793 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.39 | 1,100 | 42,229 | 8,456,393 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.38 | 1,168 | 44,828 | 8,457,493 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.37 | 2,932 | 112,501 | 8,458,661 | 8.5 M to 8.5 M (-0.03 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.36 | 1,500 | 57,540 | 8,461,593 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.35 | 1,385 | 53,115 | 8,463,093 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.34 | 1,915 | 73,421 | 8,464,478 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.33 | 3,000 | 114,990 | 8,466,393 | 8.5 M to 8.5 M (-0.04 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.32 | 4,800 | 183,936 | 8,469,393 | 8.5 M to 8.5 M (-0.06 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.31 | 1,300 | 49,803 | 8,474,193 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.30 | 2,000 | 76,600 | 8,475,493 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.29 | 1,699 | 65,055 | 8,477,493 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.28 | 2,400 | 91,872 | 8,479,192 | 8.5 M to 8.5 M (-0.03 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.27 | 1,203 | 46,039 | 8,481,592 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.26 | 4,187 | 160,195 | 8,482,795 | 8.5 M to 8.5 M (-0.05 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.25 | 4,787 | 183,103 | 8,486,982 | 8.5 M to 8.5 M (-0.06 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.24 | 5,913 | 226,113 | 8,491,769 | 8.5 M to 8.5 M (-0.07 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.23 | 735 | 28,099 | 8,497,682 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.22 | 765 | 29,238 | 8,498,417 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.21 | 1,910 | 72,981 | 8,499,182 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.20 | 1,000 | 38,200 | 8,501,092 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.19 | 3,000 | 114,570 | 8,502,092 | 8.5 M to 8.5 M (-0.04 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.18 | 2,213 | 84,492 | 8,505,092 | 8.5 M to 8.5 M (-0.03 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.17 | 1,188 | 45,346 | 8,507,305 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.16 | 1,400 | 53,424 | 8,508,493 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.15 | 1,316 | 50,205 | 8,509,893 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.14 | 1,384 | 52,786 | 8,511,209 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.13 | 300 | 11,439 | 8,512,593 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.12 | 200 | 7,624 | 8,512,893 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.11 | 100 | 3,811 | 8,513,093 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.10 | 600 | 22,860 | 8,513,193 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.09 | 400 | 15,236 | 8,513,793 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.08 | 300 | 11,424 | 8,514,193 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.07 | 1,000 | 38,070 | 8,514,493 | 8.5 M to 8.5 M (-0.01 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.06 | 1,400 | 53,284 | 8,515,493 | 8.5 M to 8.5 M (-0.02 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.05 | 200 | 7,610 | 8,516,893 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.04 | 100 | 3,804 | 8,517,093 | 8.5 M to 8.5 M (0.00 %) |
| Jul 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 38.01 | 100 | 3,801 | 8,517,193 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.85 | 6,351 | 234,034 | 8,545,145 | 8.6 M to 8.5 M (-0.07 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.84 | 5,310 | 195,620 | 8,551,496 | 8.6 M to 8.6 M (-0.06 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.83 | 4,151 | 152,881 | 8,556,806 | 8.6 M to 8.6 M (-0.05 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.82 | 4,581 | 168,672 | 8,560,957 | 8.6 M to 8.6 M (-0.05 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.81 | 2,355 | 86,688 | 8,565,538 | 8.6 M to 8.6 M (-0.03 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.80 | 4,600 | 169,280 | 8,567,893 | 8.6 M to 8.6 M (-0.05 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.79 | 1,910 | 70,269 | 8,572,493 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.78 | 2,281 | 83,895 | 8,574,403 | 8.6 M to 8.6 M (-0.03 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.77 | 3,143 | 115,568 | 8,576,684 | 8.6 M to 8.6 M (-0.04 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.76 | 4,100 | 150,716 | 8,579,827 | 8.6 M to 8.6 M (-0.05 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.75 | 5,800 | 213,150 | 8,583,927 | 8.6 M to 8.6 M (-0.07 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.74 | 900 | 33,066 | 8,589,727 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.73 | 1,613 | 59,245 | 8,590,627 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.72 | 887 | 32,571 | 8,592,240 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.71 | 300 | 11,013 | 8,593,127 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.70 | 1,800 | 66,060 | 8,593,427 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.69 | 800 | 29,352 | 8,595,227 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 400 | 14,672 | 8,596,027 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.67 | 500 | 18,335 | 8,596,427 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.66 | 1,100 | 40,326 | 8,596,927 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.65 | 700 | 25,655 | 8,598,027 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.64 | 400 | 14,656 | 8,598,727 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.63 | 400 | 14,652 | 8,599,127 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.62 | 100 | 3,662 | 8,599,527 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.61 | 400 | 14,644 | 8,599,627 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.60 | 100 | 3,660 | 8,600,027 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.59 | 100 | 3,659 | 8,600,127 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.58 | 100 | 3,658 | 8,600,227 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.57 | 100 | 3,657 | 8,600,327 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.56 | 200 | 7,312 | 8,600,427 | 8.6 M to 8.6 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.21 | 100 | 3,721 | 8,517,293 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.09 | 100 | 3,709 | 8,517,393 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.07 | 93 | 3,448 | 8,517,493 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.06 | 635 | 23,533 | 8,517,586 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.05 | 300 | 11,115 | 8,518,221 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.04 | 100 | 3,704 | 8,518,521 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.03 | 100 | 3,703 | 8,518,621 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.02 | 572 | 21,175 | 8,518,721 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.01 | 420 | 15,544 | 8,519,293 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 580 | 21,460 | 8,519,713 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.99 | 1,000 | 36,990 | 8,520,293 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.98 | 1,100 | 40,678 | 8,521,293 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.97 | 1,000 | 36,970 | 8,522,393 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.96 | 1,600 | 59,136 | 8,523,393 | 8.5 M to 8.5 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.95 | 1,500 | 55,425 | 8,524,993 | 8.5 M to 8.5 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.94 | 397 | 14,665 | 8,526,493 | 8.5 M to 8.5 M (0.00 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.93 | 600 | 22,158 | 8,526,890 | 8.5 M to 8.5 M (-0.01 %) |